From the Guidelines
Spironolactone can cause shortness of breath as a side effect, though it's not among the most common reactions, and patients experiencing this symptom should seek immediate medical attention. This medication, which is a potassium-sparing diuretic often used to treat conditions like heart failure, high blood pressure, and edema, may lead to breathing difficulties through several mechanisms. Shortness of breath could indicate a serious allergic reaction to the medication or might be related to electrolyte imbalances, particularly hyperkalemia (high potassium levels), which spironolactone can cause, as noted in the 2022 AHA/ACC/HFSA guideline for the management of heart failure 1. Additionally, in some patients with heart or lung conditions, fluid balance changes from the medication might temporarily worsen breathing symptoms.
The use of spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) has been investigated, and while it may reduce hospitalizations, it also increases the risk of hyperkalemia and worsening renal function, as seen in the TOPCAT trial 1, 2. The 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure recommends that aldosterone receptor antagonists, such as spironolactone, might be considered to decrease hospitalizations in appropriately selected patients with HFpEF, with careful monitoring of potassium and renal function 2.
It is essential for patients taking spironolactone to be closely monitored for signs of hyperkalemia and renal dysfunction, as these can be serious side effects, and the medication should only be used in patients with adequate renal function and a normal serum potassium level, as recommended in the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 3. If you experience shortness of breath while taking spironolactone, you should contact your healthcare provider immediately, as this could be a sign of a serious adverse reaction requiring prompt medical attention. Your doctor may need to adjust your dosage, switch you to an alternative medication, or evaluate for other causes of your breathing difficulties. Never stop taking spironolactone suddenly without medical guidance, as this could lead to worsening of the underlying condition being treated.
Key considerations for the management of patients with heart failure, including those taking spironolactone, include regular monitoring of symptoms, urine output, renal function, and electrolytes, as well as the use of diuretics, vasodilators, and other medications as needed to manage symptoms and improve outcomes, as outlined in the 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 4. Overall, while spironolactone can be an effective medication for certain conditions, it is crucial to be aware of its potential side effects, including shortness of breath, and to seek medical attention if symptoms occur.
From the Research
Spironolactone and Shortness of Breath
- There is no direct evidence in the provided studies that links spironolactone to shortness of breath as a side effect.
- However, spironolactone is commonly used in patients with heart failure, and shortness of breath is a common symptom of heart failure 5, 6, 7, 8.
- The studies focus on the safety and efficacy of spironolactone in patients with heart failure, and the potential risks of hyperkalemia associated with its use, particularly when combined with other medications such as ACE inhibitors or angiotensin receptor blockers 5, 6, 7, 9.
- The provided studies do not investigate the specific side effect of shortness of breath in relation to spironolactone use, but rather focus on its overall safety and efficacy in patients with heart failure and other conditions 5, 6, 7, 8, 9.